Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases—Current State of the Art
Unique characteristics distinguish extracellular signal-regulated kinases (Erks) from other eukaryotic protein kinases (ePKs). Unlike most ePKs, Erks do not autoactivate and they manifest no basal activity; they become catalysts only when dually phosphorylated on neighboring Thr and Tyr residues and...
Main Authors: | Karina Smorodinsky-Atias, Nadine Soudah, David Engelberg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/1/129 |
Similar Items
-
Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models
by: Michal Kopczynski, et al.
Published: (2021-09-01) -
BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
by: Sihan Chen, et al.
Published: (2022-08-01) -
Involvement of the ERK MAPK Cascade in the Formation of Adhesions in the Abdominal Cavity
by: I. A. Shurygina, et al.
Published: (2021-01-01) -
Editorial: Mitogen Activated Protein Kinases
by: Ana Cuenda, et al.
Published: (2017-09-01) -
Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway
by: Chong-Yi Yang, et al.
Published: (2021-01-01)